Showing 11,901 - 11,920 results of 99,011 for search '(( 50 ms decrease ) OR ( 5 ((teer decrease) OR (((a decrease) OR (nn decrease)))) ))', query time: 1.21s Refine Results
  1. 11901

    Sequences of the qPCR primers used. by Lucas H. Oronel (8525697)

    Published 2025
    “…This increase was mainly cytoplasmic, explaining the increased urinary volume of CKD rats and suggesting a possible non-canonical role for AQP2. In addition, Tolvaptan effectively inhibited the V2 receptor in both control and CKD rats, decreasing AQP2 expression and increasing diuresis. …”
  2. 11902

    Original and uncropped blots. by Lucas H. Oronel (8525697)

    Published 2025
    “…This increase was mainly cytoplasmic, explaining the increased urinary volume of CKD rats and suggesting a possible non-canonical role for AQP2. In addition, Tolvaptan effectively inhibited the V2 receptor in both control and CKD rats, decreasing AQP2 expression and increasing diuresis. …”
  3. 11903
  4. 11904
  5. 11905
  6. 11906
  7. 11907
  8. 11908
  9. 11909
  10. 11910
  11. 11911
  12. 11912
  13. 11913
  14. 11914

    DataSheet_1_microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression.docx by Stephen Fitzsimons (9856793)

    Published 2020
    “…Previous transcriptomic analysis led us to hypothesize that miR-155-5p (miR-155) is regulated by conjugated linoleic acid (CLA), a pro-resolving mediator which induces regression of atherosclerosis in vivo. …”
  15. 11915

    DataSheet_2_microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression.docx by Stephen Fitzsimons (9856793)

    Published 2020
    “…Previous transcriptomic analysis led us to hypothesize that miR-155-5p (miR-155) is regulated by conjugated linoleic acid (CLA), a pro-resolving mediator which induces regression of atherosclerosis in vivo. …”
  16. 11916
  17. 11917
  18. 11918
  19. 11919
  20. 11920